RxDoctor Payments Data

Rondel Albarado, MD

Surgical Critical Care · Houston, TXNPI 1811187057

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $155,690 of the $196,630 with a category attached, or 79.2%. 9 manufacturers reported payments, led by Mallinckrodt Enterprises LLC at 35.9% of the total. Reporting peaked in 2019 at $117,926 and has fallen 99.7% since, to $311 in 2024. Among surgical critical care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$196,630in general payments, 2019–2025

Across 198 payments — averaging $993.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Enterprises LLC$71K
  • AstraZeneca$62K
  • Portola Pharmaceuticals, LLC$53K
  • Mallinckrodt Hospital Products Inc.$11K
  • TELA Bio, Inc.$79
  • Stryker$61
  • plus $79 from 3 others

What the payments were for

  • Speaking & faculty fees$155,69079%
  • Travel & lodging$34,23817%
  • Food & beverage$6,7023%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$196,630 in reported general payments places this provider in the 95th percentile of 104 surgical critical care providers in Texas.

See all surgical critical care providers in Texas

Medicare billing

Part B allowed, 2024
$25,825
Medicare patients
74
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical critical care in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →